Author/Authors :
Ghobadi, Hassan Department of Internal Medicine - Pulmonary Division - Faculty of Medicine - Ardabil University of Medical Sciences, Ardabil, Iran , Ebrahimi Kalan, Mohammad Department of Epidemiology - Stempel College of Public Health - Florida International University, Miami, FL, USA , Mohammad-Shahi, Jafar Department of Infectious Disease - School of Medicine - Ardabil University of Medical Sciences, Ardabil, Iran , Ben Taleb, Ziyad Department of Kinesiology - College of Nursing and Health Innovation - University of Texas at Arlington - Arlington, TX, USA , Ebrahimi Kalan, Abbas Department of Neurosciences and Cognition - School of Advanced Medical Sciences - Tabriz University of Medical Sciences, Tabriz, Iran , Fazlzadeh, Mehdi Department of Environmental Health - School of Health - Ardabil University of Medical Sciences, Ardabil, Iran
Abstract :
Although there is no definitive evidence that coronavirus disease 2019 (COVID-19) affects the kidneys adversely, amongst those who develop severe COVID-19 infection and require hospitalization, acute kidney injury (AKI) was reported. Here, we report the clinical outcome associated with AKI in a 32-year-old man with confirmed COVID-19 infection with no prior history of renal malfunction. The AKI was identified during intensive care unit (ICU) course with the median creatinine and blood urea nitrogen values of 3.1 mg/dL (normal value: 0.6-1.2 mg/dL) and 145 mg/dL (normal value:15-45 mg/dL), respectively. Renal function of patients hospitalized with COVID-19 infection needs to be monitored regularly to intervene as early as possible and to prevent the development of AKI and further kidney complications.
